Where can I find ROP.SW's financial statements?

Roche Holding AG (ROP.SW)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.

How much history is available for ROP.SW?

Roche Holding AG (ROP.SW) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.

How often does ROP.SW update its statements?

Roche Holding AG files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

ROP.SW

Roche Holding AG

SIX·Drug Manufacturers, General · Healthcare

CHF 333.80CHF 2.10+0.63%

Market capCHF 265.70B·Market closed·Jul 21 3:30 PM UTC

CHF · values shown as reported

Line item	FY 2021	FY 2022	FY 2023	FY 2024	FY 2025
Revenue	CHF 62.80B+7.7%	CHF 65.81B+4.8%	CHF 60.44B−8.2%	CHF 62.40B+3.2%	CHF 61.52B−1.4%
Cost of revenue	CHF 19.70B+20.5%	CHF 17.94B−9.0%	CHF 16.36B−8.8%	CHF 16.28B−0.5%	CHF 16.28B−0.0%
Gross profit	CHF 43.10B+2.7%	CHF 47.88B+11.1%	CHF 44.08B−7.9%	CHF 46.11B+4.6%	CHF 45.24B−1.9%
Research & development	CHF 14.80B+21.8%	CHF 15.23B+2.9%	CHF 14.20B−6.7%	CHF 15.30B+7.8%	CHF 13.35B−12.8%
General & administrative	CHF 2.43B−1.4%	CHF 14.20B+485.6%	CHF 14.88B+4.8%	CHF 14.90B+0.1%	CHF 15.16B+1.8%
Selling & marketing	CHF 9.48B+0.9%	CHF 9.64B+1.7%	—	—	—
SG&A (combined)	CHF 11.87B+0.4%	CHF 14.20B+19.6%	CHF 14.88B+4.8%	CHF 14.90B+0.1%	CHF 15.16B+1.8%
Other operating expenses	−CHF 854.00M−422.3%	CHF 974.00M+214.1%	−CHF 392.00M−140.2%	CHF 2.50B+736.5%	−CHF 2.54B−201.9%
Total operating expenses	CHF 25.82B+6.5%	CHF 30.40B+17.8%	CHF 28.69B−5.6%	CHF 32.70B+14.0%	CHF 25.97B−20.6%
Operating income	CHF 18.16B+2.4%	CHF 17.48B−3.7%	CHF 15.40B−11.9%	CHF 13.42B−12.8%	CHF 19.26B+43.6%
Interest income	—	—	CHF 195.00M	CHF 260.00M+33.3%	—
Interest expense	CHF 341.00M−22.1%	CHF 608.00M+78.3%	CHF 828.00M+36.2%	CHF 1.25B+50.7%	CHF 1.35B+8.1%
Other income / (expense), net	−CHF 757.00M−31.2%	−CHF 1.15B−51.8%	−CHF 1.32B−14.5%	−CHF 1.62B−23.4%	−CHF 2.29B−41.1%
Income before tax	CHF 17.40B−3.2%	CHF 16.37B−5.9%	CHF 14.08B−14.0%	CHF 11.79B−16.2%	CHF 16.97B+43.9%
Income tax expense	CHF 2.46B−15.0%	CHF 2.80B+13.5%	CHF 1.72B−38.4%	CHF 2.61B+51.4%	CHF 3.17B+21.8%
Net income	CHF 13.93B−2.6%	CHF 12.42B−10.8%	CHF 11.50B−7.4%	CHF 8.28B−28.0%	CHF 12.88B+55.6%

EPS (basic)	CHF 16.39−2.0%	CHF 15.53−5.2%	CHF 14.39−7.3%	CHF 10.36−28.0%	CHF 16.18+56.2%
EPS (diluted)	CHF 16.20−1.9%	CHF 15.37−5.1%	CHF 14.30−7.0%	CHF 10.29−28.0%	CHF 16.04+55.9%
Weighted avg shares (basic)	850,000,000	800,000,000	799,000,000	797,000,000	796,000,000
Weighted avg shares (diluted)	860,000,000	800,000,000	804,000,000	802,000,000	803,000,000

Depreciation & amortization	CHF 4.45B−2.6%	CHF 3.82B−14.0%	CHF 3.46B−9.4%	CHF 3.42B−1.2%	CHF 3.39B−0.9%
EBITDA	CHF 22.19B−3.4%	CHF 20.80B−6.3%	CHF 18.41B−11.5%	CHF 16.62B−9.7%	CHF 22.66B+36.3%

Frequently Asked Questions About ROP.SW

Where can I find ROP.SW's financial statements?: Roche Holding AG (ROP.SW)'s full income statement, balance sheet, and cash flow statement are on this page in 10-K-style line-item format. Switch between the three statements via the pill toggle above the table.
How much history is available for ROP.SW?: Roche Holding AG (ROP.SW) statements are available back to its earliest filed 10-K — typically 10+ years of annual data and 40 quarters of quarterly data. Free-tier users see 5 years and 8 quarters; full history unlocks with a Pro account.
How often does ROP.SW update its statements?: Roche Holding AG files a 10-K annually (full audited year-end statements) and 10-Q reports quarterly (unaudited interim statements). New filings are typically parsed and reflected on this page within 48 hours of SEC submission.

Line item

FY 2021

FY 2022

FY 2023

FY 2024

FY 2025

Trend

Revenue

CHF 62.80B+7.7%

CHF 65.81B+4.8%

CHF 60.44B−8.2%

CHF 62.40B+3.2%

CHF 61.52B−1.4%

Cost of revenue

CHF 19.70B+20.5%

CHF 17.94B−9.0%

CHF 16.36B−8.8%

CHF 16.28B−0.5%

CHF 16.28B−0.0%

Gross profit

CHF 43.10B+2.7%

CHF 47.88B+11.1%

CHF 44.08B−7.9%

CHF 46.11B+4.6%

CHF 45.24B−1.9%

Research & development

CHF 14.80B+21.8%

CHF 15.23B+2.9%

CHF 14.20B−6.7%

CHF 15.30B+7.8%

CHF 13.35B−12.8%

General & administrative

CHF 2.43B−1.4%

CHF 14.20B+485.6%

CHF 14.88B+4.8%

CHF 14.90B+0.1%

CHF 15.16B+1.8%

Selling & marketing

CHF 9.48B+0.9%

CHF 9.64B+1.7%

—

SG&A (combined)

CHF 11.87B+0.4%

CHF 14.20B+19.6%

CHF 14.88B+4.8%

CHF 14.90B+0.1%

CHF 15.16B+1.8%

Other operating expenses

−CHF 854.00M−422.3%

CHF 974.00M+214.1%

−CHF 392.00M−140.2%

CHF 2.50B+736.5%

−CHF 2.54B−201.9%

Total operating expenses

CHF 25.82B+6.5%

CHF 30.40B+17.8%

CHF 28.69B−5.6%

CHF 32.70B+14.0%

CHF 25.97B−20.6%

Operating income

CHF 18.16B+2.4%

CHF 17.48B−3.7%

CHF 15.40B−11.9%

CHF 13.42B−12.8%

CHF 19.26B+43.6%

Interest income

—

CHF 195.00M

CHF 260.00M+33.3%

—

Interest expense

CHF 341.00M−22.1%

CHF 608.00M+78.3%

CHF 828.00M+36.2%

CHF 1.25B+50.7%

CHF 1.35B+8.1%

Other income / (expense), net

−CHF 757.00M−31.2%

−CHF 1.15B−51.8%

−CHF 1.32B−14.5%

−CHF 1.62B−23.4%

−CHF 2.29B−41.1%

Income before tax

CHF 17.40B−3.2%

CHF 16.37B−5.9%

CHF 14.08B−14.0%

CHF 11.79B−16.2%

CHF 16.97B+43.9%

Income tax expense

CHF 2.46B−15.0%

CHF 2.80B+13.5%

CHF 1.72B−38.4%

CHF 2.61B+51.4%

CHF 3.17B+21.8%

Net income

CHF 13.93B−2.6%

CHF 12.42B−10.8%

CHF 11.50B−7.4%

CHF 8.28B−28.0%

CHF 12.88B+55.6%

EPS (basic)

CHF 16.39−2.0%

CHF 15.53−5.2%

CHF 14.39−7.3%

CHF 10.36−28.0%

CHF 16.18+56.2%

EPS (diluted)

CHF 16.20−1.9%

CHF 15.37−5.1%

CHF 14.30−7.0%

CHF 10.29−28.0%

CHF 16.04+55.9%

Weighted avg shares (basic)

850,000,000

800,000,000

799,000,000

797,000,000

796,000,000

Weighted avg shares (diluted)

860,000,000

800,000,000

804,000,000

802,000,000

803,000,000

Depreciation & amortization

CHF 4.45B−2.6%

CHF 3.82B−14.0%

CHF 3.46B−9.4%

CHF 3.42B−1.2%

CHF 3.39B−0.9%

EBITDA

CHF 22.19B−3.4%

CHF 20.80B−6.3%

CHF 18.41B−11.5%

CHF 16.62B−9.7%

CHF 22.66B+36.3%